Facts

• Segment: Healthcare
• Country: China
• Founded: 2018
• Website: https://www.truehealth.cn/

Profile sections

• Summary
• Market context
• Facts
• Events
• Team
• Context tags
• Sources

Summary

True Health Medical develops and commercializes percutaneous puncture and ablation surgical robots in China. Its TH-S robot family has NMPA Class III registrations for lung and abdominal puncture, and the company opened Hong Kong IPO subscription on June 22, 2026 under stock code 02697. HK.

Market context

True Health Medical builds surgical robots for image-guided percutaneous puncture, biopsy and ablation workflows.

Facts

• Website: https://www.truehealth.cn/
• HQ: Zhuhai, Guangdong, China
• Founded: 2018
• Segment: Healthcare

Events

• 2026-06-22 - Market Signal - True Health Medical-B opens Hong Kong IPO subscription under 02697.HK - The subscription period runs from June 22 to June 25, 2026.

Team

• Cheong Hou Iam - Chairperson, Executive Director and General Manager - Leads True Health Medical as it advances percutaneous puncture and ablation surgical robots through Hong Kong IPO subscription and planned listing.

Context tags

• Surgical robotics companies - Peer Group - The company develops and commercializes surgical robots.
• Surgical robot OEM - Stack Layer - The company builds its TH-S puncture surgical robot family.
• Surgical navigation and planning - Capability - Its puncture robots support lesion identification, path planning and procedure guidance.
• Surgical medical intervention - Workflow - The robots support percutaneous puncture and ablation intervention workflows.
• Hospitals and surgical centres - Customer Environment - The product family is built for surgical and interventional hospital workflows.